Our mission is to unite and align key diabetes stakeholders and the larger diabetes community around key
diabetes-related policy and legislative efforts in order to elevate diabetes on the national agenda.

Screening for Prediabetes and Diabetes

Screening for diabetes is a policy priority for the Diabetes Advocacy Alliance (DAA) because screening is the entry point for detection of prediabetes and diabetes. With screening, we can:

  • Identify adults with prediabetes, who could benefit from diabetes prevention programs.
  • Identify adults with undiagnosed diabetes, enabling them to begin treatment and care to help prevent the serious health complications of diabetes.

Important Changes Coming in 2017

Federal diabetes screening guidelines were updated in October 2015. Beginning January 2017, private health plans are required to cover, at no cost to the patient:

  • Screening for prediabetes and diabetes, and
  • Participation in intensive behavioral counseling interventions (diabetes prevention programs) for individuals screened and determined to have prediabetes.

The DAA has prepared a fact sheet with details about who is eligible for free screening and potential referral to insurance-covered diabetes prevention programs. It also provides background on how these changes came to be and provides details of implications for Medicare, Medicaid and private insurers.

Benefits for Public Health
Nearly 3 times more adults are eligible for screening under the new federal screening recommendation compared to the 2008 version. Implementation of the new, comprehensive guideline has the potential to detect most cases of undiagnosed prediabetes and diabetes especially in racial and ethnic minorities who are disproportionally impacted by the disease.

Help Spread the Word
You can help educate stakeholders by using the DAA’s Toolkit to educate stakeholders about the new screening guideline and coverage implications. The toolkit contains: